Stay updated on Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.

Latest updates to the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page
- CheckyesterdayChange DetectedThe location listing changed from Tainan City, Taiwan, 704 to Tainan, Taiwan, 704; this is a minor formatting update that does not affect any functionality or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedMinor layout and content formatting updates were made to the Study Details page, with no changes to the trial design, eligibility criteria, primary outcomes, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check37 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference2%

- Check44 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.SummaryDifference0.1%

- Check58 days agoChange DetectedVersion bumped to v3.0.2; previous v3.0.1 tag and the 'Back to Top' element were removed.SummaryDifference0.1%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.